NDC Package 0069-1960-02 Cutaquig

Immunoglobulin G Solution Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
0069-1960-02
Package Description:
1 VIAL, GLASS in 1 CARTON / 20 mL in 1 VIAL, GLASS (0069-1960-01)
Product Code:
Proprietary Name:
Cutaquig
Non-Proprietary Name:
Immunoglobulin G
Substance Name:
Human Immunoglobulin G
Usage Information:
CUTAQUIG (Immune Globulin Subcutaneous (Human) - hipp) is a 16.5% immune globulin solution for subcutaneous infusion (IGSC), indicated as replacement therapy for primary humoral immunodeficiency (PI) in adults. This includes, but is not limited to, common variable immunodeficiency (CVID), X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.
11-Digit NDC Billing Format:
00069196002
NDC to RxNorm Crosswalk:
  • RxCUI: 2167147 - immune globulin subcutaneous (human) - hipp 16.5 % (1 GM in 6 mL) Injection
  • RxCUI: 2167147 - 6 ML immune globulin subcutaneous (human) - hipp 165 MG/ML Injection
  • RxCUI: 2167147 - 6 ML immune globulin subcutaneous (human) - hipp 16.5 % (1 GM per 6 ML) Injection
  • RxCUI: 2167152 - cutaquig 16.5 % (1 GM in 6 ML) Injection
  • RxCUI: 2167152 - 6 ML immune globulin subcutaneous (human) - hipp 165 MG/ML Injection [Cutaquig]
  • Product Type:
    Plasma Derivative
    Labeler Name:
    Pfizer Laboratories Div Pfizer Inc
    Dosage Form:
    Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
    Administration Route(s):
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
  • Active Ingredient(s):
    Sample Package:
    No
    FDA Application Number:
    BLA125668
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    09-13-2019
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0069-1960-02?

    The NDC Packaged Code 0069-1960-02 is assigned to a package of 1 vial, glass in 1 carton / 20 ml in 1 vial, glass (0069-1960-01) of Cutaquig, a plasma derivative labeled by Pfizer Laboratories Div Pfizer Inc. The product's dosage form is solution and is administered via subcutaneous form.

    Is NDC 0069-1960 included in the NDC Directory?

    Yes, Cutaquig with product code 0069-1960 is active and included in the NDC Directory. The product was first marketed by Pfizer Laboratories Div Pfizer Inc on September 13, 2019 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 0069-1960-02?

    The 11-digit format is 00069196002. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    4-4-20069-1960-025-4-200069-1960-02